Will Springer Nature’s 3rd IPO attempt prove successful? S2O runs into turbulence as IWA ends offering. Atypon enters the fray as CDPs heat up in ScholComm. A class action suit against scholarly publishers? Plus which journals are the most likely to inflict paper cuts?

Early 2024 data suggests a major market shift away from the leading born-OA publishers, Congress is unhappy with the OSTP’s Nelson Memo licensing terms, researchers begin to find their OA policy voice

Fuzzy numbers muddle analyses of market consolidation and APC prices. Brandification of journals is not new. Survey says … researchers need more support from publishing infrastructure.

OSTP offers no financial analysis of the Nelson Memo’s impact. NIH’s revised and retroactive Nelson Memo plan speeds up the transition to OA. Policymakers largely ignore the administrative burden of OA. And is search the wrong application for AI, a technology that is producing “bullshit”?

Do new GenAI developments signal an end to traffic to journals? Is AI training set licensing really going to pay off? Why negativity is needed for proper AI training. The implications of JACC and The Lancet’s new article transfer agreement.

Publishers are left with a cancelled check as funders who have demand journals flip to APC now pull back support for the APC model, Gates makes a “U”-turn to preprints, and society partnering decisions are complex decisions that go beyond simple measurements of revenue.

PeerJ sells to T&F, Springer Nature sells off AJE (and their new AI tool Curie), Congress puts OSTP on the hook for a financial analysis of the Nelson Memo, Jisc’s long transition, and the year in review at eLife & cOAlition S

An impressive rat brings research integrity to the news. What will US open data policies really cost? RELX’s balance sheet shows strong results. A court rules against authors in an AI fair use case. New Clarivate changes, gaming Google Scholar is easier than ever, and physics societies join forces.

The financial impacts of research integrity and the precariousness of the author-pays model. Did OA really speed the Covid response? Is there really an OA oligopoly? Also, publishers turn out to be good at publishing.

Google’s Gemini AI ingests the OA literature with uncertain implications for publisher licensing. Wiley’s new deal with DEAL offers a better approach to tiered pricing. We bid farewell to the Hindawi brand. Open Research Europe hits crossroads. A look ahead to the new Chinese Journal Early Warning List.